Park Avenue Securities LLC Buys Shares of 10,111 SPDR S&P Pharmaceuticals ETF $XPH

Park Avenue Securities LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the third quarter, HoldingsChannel reports. The firm purchased 10,111 shares of the company’s stock, valued at approximately $485,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. U.S. Capital Wealth Advisors LLC increased its position in shares of SPDR S&P Pharmaceuticals ETF by 2.6% during the third quarter. U.S. Capital Wealth Advisors LLC now owns 14,730 shares of the company’s stock worth $706,000 after acquiring an additional 378 shares during the period. Advantage Trust Co grew its stake in SPDR S&P Pharmaceuticals ETF by 1,525.0% during the 2nd quarter. Advantage Trust Co now owns 3,250 shares of the company’s stock worth $132,000 after purchasing an additional 3,050 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in SPDR S&P Pharmaceuticals ETF by 9.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 57,258 shares of the company’s stock worth $2,324,000 after purchasing an additional 4,918 shares during the period. Rockport Wealth LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at about $203,000. Finally, EP Wealth Advisors LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at about $278,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of SPDR S&P Pharmaceuticals ETF stock opened at $55.71 on Friday. The business has a 50-day simple moving average of $54.77 and a 200-day simple moving average of $48.96. SPDR S&P Pharmaceuticals ETF has a one year low of $35.22 and a one year high of $57.58. The company has a market cap of $233.98 million, a PE ratio of 14.28 and a beta of 0.60.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.